A clinical trial has demonstrated that oVRcome, a virtual reality app developed in New Zealand for treating anxiety and phobias, significantly reduces symptoms of social anxiety.

With guidance from the Johner Institute, med-tech startups can navigate complex regulations early and bring innovative products to market safely.

The MRI technique advances coming out of the Mātai Medical Research Institute in Gisborne have been described as ‘pioneering’, ‘groundbreaking’ and ‘world leading’. Claire Concannon speaks to chief executive and research director Dr Samantha Holdsworth to learn why, and about their big plans for the future.

MARS Bioimaging Ltd are a Christchurch health tech company breaking new ground in medical imaging. Co-founder and chief medical officer Anthony Butler discusses their vision, and why it makes sense to be based in Ōtautahi Christchurch.

Twenty clinicians across the motu are piloting a new AI scribe to help transcribe their patient notes and lessen their cognitive load.

Distinguished Professor Maggie-Lee Huckabee is commercialising software that measures muscle activity for patients that struggle to swallow.

Canterbury Scientific is driven by a core principle – quality science, quality products. The Christchurch company is committed to enhancing diagnostics and improving patient care with cutting-edge tools. CEO Clive Seymour outlines their approach.

The Startup Blueprint series shares insights from the founders and operators building companies & ideas defining what the world could become. Hear about their journeys, learn from their insights, and maybe leave with a dose of inspiration.

The money raised will continue its push into US hospitals.

For the second year running, the University of Auckland has come out on top in Australasia in the Survey of Commercialisation Outcomes from Public Research.

One CEO recalled needing to make a change in their leadership team. While these decisions are difficult to make, she knew that the longer you wait to make them, the more credibility you lose among your staff.‍

Raising capital is one of the biggest decisions a startup founder will face, so what option makes sense and how do you recognize the best fit?

Winners of the 12th annual KiwiNet Research Commercialisation Awards were honoured at a gala event in Auckland tonight for their success in transforming scientific discoveries into new technologies, businesses and real-world solutions.

A Christchurch-based startup is using the approach of 'by Māori, with Māori for everybody' to develop a low-cost, AI-powered, an user-friendly insulin pump.

The New Zealand-built health tech app provides new pathways for grief support, helping people navigate their grief journey with personalised tools and a supportive community.

The investment by US-based McGeever comes before an $8m Series A funding round.

We have recently developed a digital twin of the most vulnerable of cardiovascular systems – those of newborn babies. That could help answer some important questions.

Surgeons all over the world face the challenge of tediously hand-sewing micro arteries to re-establish blood flow to transplanted tissues. Avasa’s arterial coupler makes microvascular surgery quicker and safer empowering surgeons to securely and efficiently link microvascular arteries in under 10 minutes.

Dr Kelly Burrowes from the Auckland Bioengineering Institute was recently featured on Te Ao with Moana discussing her research on vaping and the harmful impacts.

Good Clinical has teamed up with Te Titoki Mataora, the MedTech Research Translator, to bring you the Te Titoki Mataora Podcast Series. In this episode, meet Dr. Yaara Yarmut, the Chief Regulatory Officer at Alimetry, a medical device company who have developed an innovative gastric monitoring device that performs body surface gastric mapping using an electrode array.

Callaghan Innovation will support seven trailblazing Kiwi businesses with bold ideas to succeed in global markets, while forging new pathways for like-minded Kiwi innovators.

From their local roots here in Aotearoa, two innovative Kiwi companies, Script Sense and Prosaic, are using AI to develop their products for the global market.

Kitea Health, has achieved a significant milestone with co-founder Natalia Lopez securing a spot to represent New Zealand at the prestigious 2024 Startup World Cup. This global competition will take place in Silicon Valley where Natalia will showcase the innovative Kitea System to a panel of over 2,500 investors, Venture Capital firms (including Pegasus Investments), and interact with other promising startups from around the world.

This month med-tech company HeartLab turns six before its founder turns 25.

Students are being transported to virtual parties and bathrooms to practise saying no to vaping, using a new technology that fills “the void” of addiction aid for schools. A pilot virtual reality (VR) programme at five New Zealand schools has seen 52% of participants report they were less inclined to pick up a vape afterwards.

The latest KiwiNet Award finalists have been announced including local MedTech start-ups and researchers.

Medtech startup Toku Eyes is hoping to raise between US$15 million and US$20m ($24m and $32m) in a Series B round under way as it rolls out its first product.

This company is doing everything right in the view of the judges and stands on the threshold of world changing success.

In 40 pages, the report quantifies the healthtech sector and its key markets, investment, and business spending. Over 230 companies are collected here, with in-depth profiles on the highest-earning companies and the most exciting start-ups .

New Zealand is no stranger to health tech innovation – from co-discovering the molecular structure of DNA to inventing the disposable syringe.

It’s an inspiring time for New Zealand’s MedTech industry both at home and on the global stage.

The developer of the world's smallest brain implant, Kitea Health, says it not only alerts parents when pressure is building in their child's brain, but will take the pressure off families living in constant fear of a serious medical event.

Medtech startup Avasa is raising US $7.5M in Series A round

More than 40 percent of New Zealand women have problems with incontinence, according to new research. Otago University Professor Jean Hay-Smith, co-author of the research which was published in The New Zealand Medical Journal on Friday, said the social stigma of incontinence meant many women were not getting the help they needed.

In a world-first, start-up Kitea Health has successfully implanted a chip under an Auckland patient’s skull that will monitor fluid pressure - part of a trial that will expand to 20 patients. The startup is now seeking $20m in a Series A raise, which will help fund a wider trial involving 150 patients across NZ and the US, with the goal of gaining FDA approval in around a couple of years.

Over the last 10 years Ōtepoti-Dunedin has seen significant growth and investment contributing to the establishment and scaling up of businesses. From startups, health tech to game development, these are the Dunedin sectors to watch.

Kings Birthday Honours 2024, a new Knight Companion in MedTech

Chemical engineer Sandra Grau-Bartual backed herself as the best person to lead her startup and is learning to be a founder along the way. Even though she knew it was the right move, it was still a scary one, she says. As a chemical engineer, not a businessperson, she worried she wouldn’t actually enjoy the role of CEO. With no idea where to start, she turned to a mentor, who reminded her that it’s normal for most founders to not know what to do. It’s a message Grau-Bartual now wants to normalise for others making the jump from academic research to startup founder.

Junofem's Femfit pelvic floor trainer has been rated almost five stars by popular London-based women's lifestyle magazine 'Women & Home'.

Callaghan says the government backed programme has created 35 deep tech ventures to date